Leaders are recognized and thrive throughout our organization.
Glenn J. Gormley, M.D., Ph. D.
Co-Head, Research & Development,
Daiichi Sankyo;
Global Head of Development,
President,
Daiichi Sankyo Pharma Development (DSPD)
Dr. Glenn Gormley is Chief Science Officer and co-head of world-wide Research & Development at Daiichi Sankyo. He also holds the position of Global Head of Development and President of Daiichi Sankyo Pharma Development (DSPD). In his role as Global Head of Development, Dr. Gormley co-chairs the Executive Management decision body for R&D and oversees the four regional development organizations: Americas Region, EU/India Region, Japan Region and Asia Development Region. In his role as President of DSPD, Dr. Gormley is a board member of Daiichi Sankyo Incorporated.
He was formerly Chief Executive Officer of Gemin X Pharmaceuticals, a North American oncology company. Prior to Gemin X, Dr. Gormley held the position of Global Head of Clinical Development and Medical Affairs at Novartis. Before joining Novartis, Dr. Gormley served as Chief Medical Officer for AstraZeneca, where he continued his academic appointment as a member of the Clinical Faculty at New York University and served as a Trustee of the University of Delaware. He spent 12 years at Merck as Vice President of Clinical Development following his education.
Dr. Gormley has a keen interest in ensuring patients have access to treatments to improve their lives, and as such volunteers on a number of boards and committees, including the Board of Directors for the American Society of Clinical Pharmacology (ASCPT), the Board of Directors of the Biotechnology Industry Organization (BIO) and the PhRMA Science and Regulatory Committee.
Dr. Gormley received his M.D. and Ph.D. in Chemistry from the University of Chicago and received board certifications in Pediatrics from UCLA and Endocrinology from New York University. Since that time he has remained committed to the fields of clinical pharmacology and endocrinology and published many papers of original research.
©2011 Daiichi Sankyo Inc. All Rights Reserved.
As of 10/2011
